Bone: Does TSH concentration influence skeletal health?

Nature Reviews Endocrinology

Volumn 5, Issue 5, 2009, Pages 245-246

  Bauer, Douglas C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITOMETRY; FRACTURE; HYPERTHYROIDISM; OSTEOLYSIS; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; BONE DENSITY; HUMAN; METABOLISM; NOTE; PHYSIOLOGY;

THYROTROPIN;

BONE DENSITY; FRACTURES, BONE; HUMANS; THYROTROPIN;

EID: 67651176134     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.59     Document Type: Short Survey

References (7)

1. Murphy, E. & Williams, G. R. The thyroid and the skeleton. Clin. Endocrinol. (Oxf.) 61, 285-298 (2004).
2. Vestergaard, P. & Mosekilde, L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12, 411-419 (2002). (Pubitemid 34602601)
3. Uzzan, B., et al. Effects on bone mass of long term treatment with thyroid hormones: a metaanalysis. J. Clin. Endocrinol. Metab. 81, 4278-4289 (1996).
4. Grimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y. & Jorde, R. The relationship between serum TsH and bone mineral density in men and postmenopausal women: the Tromsø study. Thyroid 18, 1147-1155 (2008).
5. Bauer, D. C., Ettinger, B., Nevitt, M. C. & Stone, K. L. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann. Intern. Med. 134, 561-568 (2001).
6. Bassett, J. H. & Williams, G. R. Critical role of the hypothalamic-pituitary-thyroid axis in bonE. Bone 43, 418-426 (2008).
7. Majima, T., et al. Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease. J. Bone Miner. Metab. 24, 105-113 (2006).